Dr.EndoIndy said:Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c…
Before/after bloodwork compilation for the lipid panel — everything in one place for those who want comprehensive data:
| Category | Marker | Before | After 15mo | Change |
|---|---|---|---|---|
| Metabolic | A1C | 7.2% | 5.7% | ⬇️ 1.4% |
| Metabolic | Fasting Glucose | 131 | 92 | ⬇️ 26 |
| Lipids | LDL | 149 | 93 | ⬇️ 51 |
| Lipids | Triglycerides | 251 | 121 | ⬇️ 121 |
| Inflammation | hsCRP | 8.5 | 0.9 | ⬇️ 5.0 |
Every single metabolic marker improved. This is why I'm a believer in this therapy.
BiostatsBrad said:Agreed, and reference ranges are laboratory-specific.
Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.
Dr.EndoIndy said:Quarterly for the first year is convention rather than evidence, and it is defensible for a simple reason: it is roughly the interval over which HbA1c…
Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would drop the "get everything" instinct further than this thread does. Every extra test is another chance at a false positive, and incidental findings have their own cost in scans, biopsies and worry.
Worth separating that from the baseline and follow-up panel, which this thread keeps folding into the same question. They behave differently and the advice does not transfer.
Sigma-Aldrich — Research-Grade Standards
Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.
Shop Reference StandardsLipidDoc_ATL said:Trying to work out whether my panel improved or merely rearranged itself, because two of the numbers went the wrong way.
Advanced lipoprotein testing on the lipid panel — going beyond standard lipid panel:
| Marker | Baseline | Month 8 | Clinical Meaning |
|---|---|---|---|
| LDL-P | 1587 | 987 | Particle count (more precise than LDL-C) |
| Small dense LDL | 67% | 31% | Atherogenic pattern |
| Remnant cholesterol | 35 | 16 | Triglyceride-rich lipoproteins |
| oxLDL | 72 | 45 | Oxidative stress marker |
The shift from small dense to large buoyant LDL is particularly important — it represents a fundamental change in the atherogenic profile.
Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.